Definition of Zanubrutinib. Meaning of Zanubrutinib. Synonyms of Zanubrutinib

Here you will find one or more explanations in English for the word Zanubrutinib. Also in the bottom left of the page several parts of wikipedia pages related to the word Zanubrutinib and, of course, Zanubrutinib synonyms and on the right images related to the word Zanubrutinib.

Definition of Zanubrutinib

No result for Zanubrutinib. Showing similar results...

Meaning of Zanubrutinib from wikipedia

- Zanubrutinib, sold under the brand name Brukinsa, is an anticancer medication used for the treatment of mantle cell lymphoma (MCL), Waldenström's macroglobulinemia...
- pharmaceuticals, including tislelizumab, a checkpoint inhibitor, and zanubrutinib, a Bruton's tyrosine kinase inhibitor. In addition to clinical research...
- Chronic lymphocytic leukemia (CLL) and Small lymphocytic lymphoma (SLL) Zanubrutinib (Brukinsa) for mantle cell lymphoma, chronic lymphocytic leukemia (CLL)...
- treatment. Autologous bone marrow transplantation is a treatment option. Zanubrutinib is indicated for the treatment of adults with Waldenström macroglobulinemia...
- Binimetinib Cobimetinib Selumetinib Trametinib EML4-ALK Crizotinib Entrectinib Lorlatinib Bruton's Acalabrutinib Ibrutinib Pirtobrutinib Zanubrutinib...
- 5'-Guanidinonaltrindole (5'-GNTI) 6'-Guanidinonaltrindole (6'-GNTI) Zanubrutinib This set index page lists chemical structure articles ****ociated with...
- Binimetinib Cobimetinib Selumetinib Trametinib EML4-ALK Crizotinib Entrectinib Lorlatinib Bruton's Acalabrutinib Ibrutinib Pirtobrutinib Zanubrutinib...
- BTK inhibitors received were ibrutinib (67%), acalabrutinib (30%), and zanubrutinib (8%); 83% had discontinued their last BTK inhibitor due to refractory...
- L01EK04 Fruquintinib L01EL01 Ibrutinib L01EL02 Acalabrutinib L01EL03 Zanubrutinib L01EL04 Orelabrutinib L01EL05 Pirtobrutinib L01EM01 Idelalisib L01EM02...
- Elexacaftor/tezacaftor/ivacaftor Vertex Pharmaceuticals cystic fibrosis Zanubrutinib BeiGene mantle cell lymphoma Crizanlizumab-tmca Novartis sickle cell...